{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:16:31Z","timestamp":1785294991941,"version":"3.55.0"},"reference-count":62,"publisher":"Rockefeller University Press","issue":"11","content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1998,6,1]]},"abstract":"<jats:p>Aplastic anemia may be associated with persistent viral infections that result from failure of the immune system to control virus. To evaluate the effects on hematopoiesis exerted by sustained viral replication in the presence of activated T cells, blood values and bone marrow (BM) function were analyzed in chronic infection with lymphocytic choriomeningitis virus (LCMV) in perforin-deficient (P0\/0) mice. These mice exhibit a vigorous T cell response, but are unable to eliminate the virus. Within 14 d after infection, a progressive pancytopenia developed that eventually was lethal due to agranulocytosis and thrombocytopenia correlating with an increasing loss of morphologically differentiated, pluripotent, and committed progenitors in the BM. This hematopoietic disease caused by a noncytopathic chronic virus infection was prevented by depletion of CD8+, but not of CD4+, T cells and accelerated by increasing the frequency of LCMV-specific CD8+ T cells in T cell receptor (TCR) transgenic (tg) mice. LCMV and CD8+ T cells were found only transiently in the BM of infected wild-type mice. In contrast, increased numbers of CD8+ T cells and LCMV persisted at high levels in antigen-presenting cells of infected P0\/0 and P0\/0 \u00d7 TCR tg mice. No cognate interaction between the TCR and hematopoietic progenitors presenting either LCMV-derived or self-antigens on the major histocompatibility complex was found, but damage to hematopoiesis was due to excessive secretion and action of tumor necrosis factor (TNF)\/lymphotoxin (LT)-\u03b1 and interferon (IFN)-\u03b3 produced by CD8+ T cells. This was studied in double-knockout mice that were genetically deficient in perforin and TNF receptor type 1. Compared with P0\/0 mice, these mice had identical T cell compartments and T cell responses to LCMV, yet they survived LCMV infection and became life-long virus carriers. The numbers of hematopoietic precursors in the BM were increased compared with P0\/0 mice after LCMV infection, although transient blood disease was still noticed. This residual disease activity was found to depend on IFN-\u03b3\u2013producing LCMV-specific T cells and the time point of hematopoietic recovery paralleled disappearance of these virus-specific, IFN-\u03b3\u2013producing CD8+ T cells. Thus, in the absence of IFN-\u03b3 and\/or TNF\/LT-\u03b1, exhaustion of virus-specific T cells was not hampered.<\/jats:p>","DOI":"10.1084\/jem.187.11.1903","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T16:49:30Z","timestamp":1027702170000},"page":"1903-1920","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":115,"title":["Aplastic Anemia Rescued by Exhaustion of Cytokine-secreting CD8+ T Cells in Persistent Infection with Lymphocytic Choriomeningitis Virus"],"prefix":"10.1084","volume":"187","author":[{"given":"Daniel","family":"Binder","sequence":"first","affiliation":[{"name":"From the *Institute of Experimental Immunology, Department of Pathology, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; the \u2021Division of Hematology, Department of Internal Medicine, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; and the \u00a7CNS Department, Pharmaceutical Research Gene Technologies, F. Hoffmann\u2013La Roche Ltd., CH-4070 Basel, Switzerland"},{"name":"From the *Institute of Experimental Immunology, Department of Pathology, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; the \u2021Division of Hematology, Department of Internal Medicine, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; and the \u00a7CNS Department, Pharmaceutical Research Gene Technologies, F. Hoffmann\u2013La Roche Ltd., CH-4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maries F.","family":"van den Broek","sequence":"additional","affiliation":[{"name":"From the *Institute of Experimental Immunology, Department of Pathology, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; the \u2021Division of Hematology, Department of Internal Medicine, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; and the \u00a7CNS Department, Pharmaceutical Research Gene Technologies, F. Hoffmann\u2013La Roche Ltd., CH-4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"K\u00e4gi","sequence":"additional","affiliation":[{"name":"From the *Institute of Experimental Immunology, Department of Pathology, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; the \u2021Division of Hematology, Department of Internal Medicine, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; and the \u00a7CNS Department, Pharmaceutical Research Gene Technologies, F. Hoffmann\u2013La Roche Ltd., CH-4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Bluethmann","sequence":"additional","affiliation":[{"name":"From the *Institute of Experimental Immunology, Department of Pathology, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; the \u2021Division of Hematology, Department of Internal Medicine, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; and the \u00a7CNS Department, Pharmaceutical Research Gene Technologies, F. Hoffmann\u2013La Roche Ltd., CH-4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Fehr","sequence":"additional","affiliation":[{"name":"From the *Institute of Experimental Immunology, Department of Pathology, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; the \u2021Division of Hematology, Department of Internal Medicine, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; and the \u00a7CNS Department, Pharmaceutical Research Gene Technologies, F. Hoffmann\u2013La Roche Ltd., CH-4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hengartner","sequence":"additional","affiliation":[{"name":"From the *Institute of Experimental Immunology, Department of Pathology, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; the \u2021Division of Hematology, Department of Internal Medicine, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; and the \u00a7CNS Department, Pharmaceutical Research Gene Technologies, F. Hoffmann\u2013La Roche Ltd., CH-4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf M.","family":"Zinkernagel","sequence":"additional","affiliation":[{"name":"From the *Institute of Experimental Immunology, Department of Pathology, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; the \u2021Division of Hematology, Department of Internal Medicine, University Hospital of Z\u00fcrich, CH-8091 Z\u00fcrich, Switzerland; and the \u00a7CNS Department, Pharmaceutical Research Gene Technologies, F. Hoffmann\u2013La Roche Ltd., CH-4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[1998,6,1]]},"reference":[{"key":"2023072507480976500_B1","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1073\/pnas.73.8.2890","article-title":"Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis","volume":"73","author":"Kagan","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072507480976500_B2"},{"key":"2023072507480976500_B3","first-page":"65","article-title":"Suppression of hematopoiesis by activated T-cells in infectious mononucleosis associated with pancytopenia","volume":"54","author":"Iishi","year":"1991","journal-title":"Int J Hematol"},{"key":"2023072507480976500_B4","first-page":"264","article-title":"Aplastic anemia following infectious mononucleosis: possible immune etiology","volume":"7","author":"Shadduck","year":"1979","journal-title":"Exp Hematol (NY)"},{"key":"2023072507480976500_B5","first-page":"38","article-title":"The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells","volume":"17","author":"Apperley","year":"1989","journal-title":"Exp Hematol (NY)"},{"key":"2023072507480976500_B6","doi-asserted-by":"crossref","first-page":"A125","DOI":"10.1007\/BF01715364","article-title":"Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma","volume":"64","author":"Reddehase","year":"1992","journal-title":"Ann Hematol"},{"key":"2023072507480976500_B7","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood.V76.12.2476.2476","article-title":"Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus","volume":"76","author":"Molina","year":"1990","journal-title":"Blood"},{"key":"2023072507480976500_B8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJM199704103361504","article-title":"Hepatitis-associated aplastic anemia","volume":"336","author":"Brown","year":"1997","journal-title":"N Engl J Med"},{"key":"2023072507480976500_B9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM198808183190702","article-title":"Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis","volume":"319","author":"Tzakis","year":"1988","journal-title":"N Engl J Med"},{"key":"2023072507480976500_B10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00007890-197611000-00020","article-title":"HLA antigens and haplotypes in 200 patients with aplastic anemia","volume":"22","author":"Albert","year":"1976","journal-title":"Transplantation"},{"key":"2023072507480976500_B11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2141.1986.tb07494.x","article-title":"Increased frequency of DR2 in patients with aplastic anaemia and increased DR sharing in their parents","volume":"63","author":"Chapuis","year":"1986","journal-title":"Br J Haematol"},{"key":"2023072507480976500_B12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/bmj.282.6267.860","article-title":"Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation","volume":"282","author":"Speck","year":"1981","journal-title":"Br Med J"},{"key":"2023072507480976500_B13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0140-6736(72)90292-9","article-title":"Aplastic anaemia treated by marrow transplantation","volume":"1","author":"Thomas","year":"1972","journal-title":"Lancet"},{"key":"2023072507480976500_B14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM199705083361906","article-title":"The pathophysiology of acquired aplastic anemia","volume":"336","author":"Young","year":"1997","journal-title":"New Engl J Med"},{"key":"2023072507480976500_B15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.185.3.517","article-title":"Virus-induced transient bone marrow aplasia: major role of interferon-alpha\/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus","volume":"185","author":"Binder","year":"1997","journal-title":"J Exp Med"},{"key":"2023072507480976500_B16","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"M\u00fcller","year":"1994","journal-title":"Science"},{"key":"2023072507480976500_B17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-065X.1996.tb00909.x","article-title":"Immunopathology or organ-specific autoimmunity as a consequence of virus infection","volume":"152","author":"Aichele","year":"1996","journal-title":"Immunol Rev"},{"key":"2023072507480976500_B18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/238335a0","article-title":"Requirement for theta-bearing cells in lymphocytic choriomeningitis virus\u2013induced central nervous system disease","volume":"238","author":"Cole","year":"1972","journal-title":"Nature"},{"key":"2023072507480976500_B19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.164.4.1075","article-title":"T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus","volume":"164","author":"Zinkernagel","year":"1986","journal-title":"J Exp Med"},{"key":"2023072507480976500_B20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1084\/jem.167.5.1749","article-title":"Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells","volume":"167","author":"Leist","year":"1988","journal-title":"J Exp Med"},{"key":"2023072507480976500_B21","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1084\/jem.183.5.2143","article-title":"Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity","volume":"183","author":"K\u00e4gi","year":"1996","journal-title":"J Exp Med"},{"key":"2023072507480976500_B22","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1084\/jem.184.6.2371","article-title":"Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease","volume":"184","author":"Evans","year":"1996","journal-title":"J Exp Med"},{"key":"2023072507480976500_B23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1101\/SQB.1962.027.001.046","article-title":"The biology of lymphocytic choriomeningitis infection: virus induced immune disease","volume":"27","author":"Hotchin","year":"1962","journal-title":"Cold Spring Harbor Symp Quant Biol"},{"key":"2023072507480976500_B24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.156.1.79","article-title":"Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections","volume":"156","author":"Pfau","year":"1982","journal-title":"J Exp Med"},{"key":"2023072507480976500_B25","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1347959","article-title":"LCMV-specific, class II\u2013 restricted cytotoxic T cells in beta 2-microglobulin\u2013deficient mice","volume":"255","author":"Muller","year":"1992","journal-title":"Science"},{"key":"2023072507480976500_B26","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1073\/pnas.85.3.822","article-title":"Number and continuous proliferative pattern of transplanted primitive immunohematopoietic stem cells","volume":"85","author":"Harrison","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072507480976500_B27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/369031a0","article-title":"Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice","volume":"369","author":"K\u00e4gi","year":"1994","journal-title":"Nature"},{"key":"2023072507480976500_B28","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/364798a0","article-title":"Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.","volume":"364","author":"Rothe","year":"1993","journal-title":"Nature"},{"key":"2023072507480976500_B29","first-page":"1","article-title":"Lymphocytic choriomeningitis virus","volume":"10","author":"Lehmann-Grube","year":"1971","journal-title":"Monogr Virol"},{"key":"2023072507480976500_B30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates","volume":"33","author":"Battegay","year":"1991","journal-title":"J Virol Methods"},{"key":"2023072507480976500_B31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/312548a0","article-title":"Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo","volume":"312","author":"Cobbold","year":"1984","journal-title":"Nature"},{"key":"2023072507480976500_B32","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/jvi.63.6.2813-2819.1989","article-title":"Enhanced virus replication and inhibition of lymphocytic choriomeningitis disease in anti-gamma interferon-treated mice","volume":"63","author":"Leist","year":"1989","journal-title":"J Virol"},{"key":"2023072507480976500_B33","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1084\/jem.162.6.2125","article-title":"Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J","volume":"162","author":"Zinkernagel","year":"1985","journal-title":"Exp Med"},{"key":"2023072507480976500_B34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-1759(91)90390-2","article-title":"Caveats and suggestions for the ELISA","volume":"137","author":"Pruslin","year":"1991","journal-title":"J Immunol Methods"},{"key":"2023072507480976500_B35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.1995.tb00686.x","article-title":"Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance","volume":"146","author":"K\u00e4gi","year":"1995","journal-title":"Immunol Rev"},{"key":"2023072507480976500_B36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1084\/jem.164.1.263","article-title":"Gamma-interferon and lymphotoxin released by activated T cells synergize to inhibit granulocyte\/monocyte colony formation","volume":"164","author":"Murphy","year":"1986","journal-title":"J Exp Med"},{"key":"2023072507480976500_B37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.1984.tb06063.x","article-title":"Analysis of lymphocyte subsets in patients with aplastic anaemia","volume":"58","author":"Zoumbos","year":"1984","journal-title":"Br J Haematol"},{"key":"2023072507480976500_B38","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1182\/blood.V79.10.2532.bloodjournal79102532","article-title":"Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia","volume":"79","author":"Nakao","year":"1992","journal-title":"Blood"},{"key":"2023072507480976500_B39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.82.1.188","article-title":"Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo","volume":"82","author":"Zoumbos","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072507480976500_B40","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1182\/blood.V78.5.1268.1268","article-title":"Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients","volume":"78","author":"Viale","year":"1991","journal-title":"Blood"},{"key":"2023072507480976500_B41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.160.2.521","article-title":"Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence","volume":"160","author":"Ahmed","year":"1984","journal-title":"J Exp Med"},{"key":"2023072507480976500_B42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1128\/jvi.69.2.1059-1070.1995","article-title":"Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression","volume":"69","author":"Borrow","year":"1995","journal-title":"J Virol"},{"key":"2023072507480976500_B43","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1172\/JCI115170","article-title":"Clonal analysis of CD4+\/CD8+ T cells in a patient with aplastic anemia","volume":"87","author":"Moebius","year":"1991","journal-title":"J Clin Invest"},{"key":"2023072507480976500_B44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenesinfection","volume":"73","author":"Pfeffer","year":"1993","journal-title":"Cell"},{"key":"2023072507480976500_B45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-5699(92)90116-O","article-title":"Two TNF receptors","volume":"13","author":"Tartaglia","year":"1992","journal-title":"Immunol Today"},{"key":"2023072507480976500_B46","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood.V72.6.1875.1875","article-title":"In vivo hematopoietic effects of tumor necrosis factor\u2013alpha in normal and erythroleukemic mice: characterization and therapeutic applications","volume":"72","author":"Johnson","year":"1988","journal-title":"Blood"},{"key":"2023072507480976500_B47","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.4049\/jimmunol.150.11.5185","article-title":"Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor\u2013alpha","volume":"150","author":"Ohashi","year":"1993","journal-title":"J Immunol"},{"key":"2023072507480976500_B48","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1073\/pnas.93.10.4589","article-title":"Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver","volume":"93","author":"Guidotti","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072507480976500_B49","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V72.4.1316.1316","article-title":"Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells","volume":"72","author":"Sieff","year":"1988","journal-title":"Blood"},{"key":"2023072507480976500_B50","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.4049\/jimmunol.131.3.1300","article-title":"Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells","volume":"131","author":"Broxmeyer","year":"1983","journal-title":"J Immunol"},{"key":"2023072507480976500_B51","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1182\/blood.V87.10.4149.bloodjournal87104149","article-title":"Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition","volume":"87","author":"Selleri","year":"1996","journal-title":"Blood"},{"key":"2023072507480976500_B52","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1084\/jem.164.6.2113","article-title":"Gamma interferon enhances macrophage transcription of the tumor necrosis factor\/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors","volume":"164","author":"Collart","year":"1986","journal-title":"J Exp Med"},{"key":"2023072507480976500_B53","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1073\/pnas.81.15.4917","article-title":"Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts","volume":"81","author":"Collins","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023072507480976500_B54","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-gamma receptor","volume":"259","author":"Huang","year":"1993","journal-title":"Science"},{"key":"2023072507480976500_B55","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/eji.1830261235","article-title":"Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo","volume":"26","author":"Speiser","year":"1996","journal-title":"Eur J Immunol"},{"key":"2023072507480976500_B56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"key":"2023072507480976500_B57","first-page":"542","article-title":"Experimental immunologically mediated aplastic anemia (AA) in H-2k identical, Mls (M) locus different mice","volume":"11","author":"Knospe","year":"1983","journal-title":"Exp Hematol (NY)"},{"key":"2023072507480976500_B58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.180.1.307","article-title":"Profound atrophy of the bone marrow reflecting major histocompatibility complex class II\u2013restricted destruction of stem cells by CD4+ cells","volume":"180","author":"Sprent","year":"1994","journal-title":"J Exp Med"},{"key":"2023072507480976500_B59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000391864","article-title":"Persistent and slow virus infections","volume":"3","author":"Hotchin","year":"1971","journal-title":"Monogr Virol"},{"key":"2023072507480976500_B60"},{"key":"2023072507480976500_B61","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.V84.11.3685.bloodjournal84113685","article-title":"Aplastic anemia: analysis of stromal cell function in long-term marrow cultures","volume":"84","author":"Holmberg","year":"1994","journal-title":"Blood"},{"key":"2023072507480976500_B62","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/blood.V75.1.96.96","article-title":"Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta","volume":"75","author":"Cashman","year":"1990","journal-title":"Blood"}],"container-title":["The Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/187\/11\/1903\/1686882\/98-0374.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/187\/11\/1903\/1686882\/98-0374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T08:36:57Z","timestamp":1690274217000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/187\/11\/1903\/7394\/Aplastic-Anemia-Rescued-by-Exhaustion-of-Cytokine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6,1]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,6,1]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.187.11.1903","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6,1]]}}}